文献速递脊柱关节炎痛风与晶体性关节病

银屑病关节炎疾病活动度与高尿酸血症可预测心血管事件:CARMA队列10年前瞻性评估

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.
PubMed 文献 · Semin Arthritis Rheum · 2026-01-11

基于CARMA项目10年前瞻性随访,纳入682例基线无心血管事件的银屑病关节炎患者。随访6397患者年期间85例(12.46%)发生心血管事件,发生率1.33/100患者年。校正PREVENT-CVD评分后,DAS28-ESR最高三分位仍为心血管事件的显著预测因子(HR 1.79;95%CI 1.03-3.14;p=0.04);尿酸≥9.0 mg/dl在校正模型中亦与心血管事件风险升高相关(HR 3.50;95%CI 1.10-11.2;p=0.02)。

要点

  • DAS28-ESR最高三分位在10年随访中独立预测PsA患者心血管事件。
  • 尿酸≥9.0 mg/dl在调整PREVENT-CVD后仍与心血管事件风险升高相关。
  • HAQ最高三分位与心血管风险的关联在校正后未持续存在。

核心结论

  • 疾病活动度和尿酸升高可独立预测银屑病关节炎患者的心血管事件,其价值超出PREVENT-CVD评分所涵盖的传统危险因素。

研究设计与样本

  • CARMA项目为多中心前瞻性队列研究,2010年7月至2012年1月从67家西班牙医院纳入725例PsA患者,分析聚焦基线无既往心血管事件的682例,随访10年。

主要发现

  • 6397患者年随访期间85例(12.46%)发生心血管事件,线性化事件率为1.33/100患者年。
  • 发生心血管事件者年龄更大(67.1±11.1 vs. 56.7±11.8岁,p<0.001)、男性更多(68.2% vs. 51.9%,p=0.005)、高血压(60.0% vs. 21.8%,p<0.001)、糖尿病(18.8% vs. 6.0%,p=0.001)、血脂异常(56.5% vs. 29.8%,p<0.001)比例更高,腹围与体重指数亦更高(均p<0.05)。
  • 校正PREVENT-CVD后DAS28-ESR最高三分位为心血管事件的显著预测因子(HR 1.79;95%CI 1.03-3.14;p=0.04)。
  • 尿酸最高三分位在粗模型中独立相关(HR 1.88;95%CI 1.11-3.20;p=0.02),尿酸≥9.0 mg/dl在调整模型中仍与风险升高相关(HR 3.50;95%CI 1.10-11.2;p=0.02)。
  • HAQ第三三分位在粗分析中与心血管风险升高相关(HR 1.70;p=0.04),校正后该关联未持续存在。

关键数值与推荐

  • DAS28-ESR按三分位分组,最高三分位vs其余为心血管事件预测因子(校正HR 1.79;95%CI 1.03-3.14;p=0.04)。
  • 尿酸按<6.5、6.5-8.9、≥9.0 mg/dl分层,≥9.0 mg/dl在调整模型中与心血管事件风险升高相关(HR 3.50;95%CI 1.10-11.2;p=0.02)。

临床怎么用

  • 在PsA长期管理中,可将DAS28-ESR所反映的疾病活动度与尿酸水平作为传统心血管风险评估之外的补充风险标记。
  • 对尿酸≥9.0 mg/dl或DAS28-ESR处于最高三分位的PsA患者,宜加强心血管风险监测与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify predictors of cardiovascular (CV) events in psoriatic arthritis (PsA) patients from the CARdiovascular in RheuMAtology (CARMA) project during 10 years of prospective follow-up. METHODS: Between July 2010 and January 2012, 725 PsA patients were enrolled from 67 Spanish hospitals. Analyses focused on 682 patients without prior CV events at baseline. At 10-year follow-up, CV event occurrence, patient-years, and linearized event rates were evaluated. Cox regression analyses were performed, both crude and adjusted for the PREVENT-CVD score. RESULTS: Over 6397 patient-years, 85 patients (12.46%) experienced CV events, yielding a rate of 1.33 per 100 patient-years. Patients with CV events were older (67.1 ± 11.1 vs. 56.7 ± 11.8 years, p < 0.001), more often male (68.2% vs. 51.9%, p = 0.005), and had higher frequencies of hypertension (60.0% vs. 21.8%, p < 0.001), diabetes (18.8% vs. 6.0%, p = 0.001), and dyslipidemia (56.5% vs. 29.8%, p < 0.001). They also showed greater abdominal perimeter and body mass index (p < 0.05 for both). After adjusting for PREVENT-CVD, the highest tertile of DAS28-ESR remained a significant predictor of CV events (HR 1.79; 95%CI: 1.03-3.14; p = 0.04). Urate in the highest tertile was also independently associated in the crude model (HR 1.88; 95%CI: 1.11-3.20; p = 0.02). When stratified (<6.5, 6.5-8.9, and ≥9.0 mg/dl), urate≥9.0 mg/dl was also associated with increased risk of CV events in the adjusted model (HR 3.50; 95%CI: 1.10-11.2; p = 0.02). While HAQ score in the third tertile was associated with increased CV risk in the crude analysis (HR 1.70; p = 0.04), this association did not persist after adjustment. CONCLUSIONS: Disease activity and elevated urate levels independently predict CV events in PsA, highlighting their value as markers of CV risk beyond traditional factors captured by the PREVENT-CVD score.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Llorca J, Ferraz-Amaro I, Moreno-Martínez MJ, et al. Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort. Semin Arthritis Rheum. 2026. PMID: 41548490. doi:10.1016/j.semarthrit.2026.152923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。